Michael Schuster Co-Founded Mesoblast Limited and Angioblast Systems Inc. in 2004. He was part of the executive management team at both companies and currently serves as the head of pharma partnering and project management at Mesoblast Limited and was previously the head of the company's investor relations outreach program.

Mr. Schuster was Executive Vice President of Global Therapeutic Programs from 2010 to 2013 and was the Director of Business Development and Vice President of Operations from 2004 to 2010.

He holds an undergraduate degree in science from Tufts University, a Master's degree in Immunology & Microbiology from New York Medical College, and an MBA from Fordham University in New York.